The Federal Trade Commission is stepping up its crackdown on so-called "junk ... on," FTC Chair Lina Khan said. The agency sent letters to 10 companies, warning that their patent listings were ...
FTC’s latest action targets more than 300 Orange Book patent listings across 10 different companies, which brings the total to more than 400 patent listings across 14 companies and should send a ...
the FTC highlighted specifically its disputes of so-called “junk patent listings” for “blockbuster” weight loss medications. To date, the FTC’s Orange Book patent disputes have been ...
Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to antitrust lawsuits, and those can be pretty expensive. But the FTC hasn’t announced if and when ...
The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time, disputing hundreds of “junk” patents ... “By filing bogus patent listings, pharma companies ...
But other companies argue that the FTC’s accusation that their patents are junk isn’t accurate. Gabriel: If drug manufacturers don’t remove their junk patent listings, they’ll open themselves up to ...
Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the ... "By challenging junk patent filings, the FTC is fighting these ...
So, being able to successfully list a patent in the Orange Book can basically allow you to shut out competitors. In practice, the FTC ... to these listings, which some people call "junk patents ...
Read Next: Federal Trade Commission Targets ‘Junk Patent Listings’ For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca. Price Action: TEVA shares are up 15. ...